Prime Medicine, Inc. Common Stock
XNAS:PRME
3.51
$3.95 - 100.00
$3.52 - 70.00
$3.48
$3.74
$3.7
$3.82
6.94
1.11
2676238
3856475.5
93816078.08
Chart
TendieTensor AI Analysis
Company
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Fundamentals
214
-2.370000
3.899900
-0.32
100
BBG011RT3R55
BBG011RT3R64
134.57M
178.27M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own PRME. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.